ONIVYDE 4.3 MG
IRINOTECAN (IRINOTECAN SUCROSE OCTASULFATE) : 4.3 MG · DIN 02467135 · IPSEN BIOPHARMACEUTICALS CANADA INC
Health Canada status: CANCELLED POST MARKET
What is ONIVYDE?
ONIVYDE 4.3 MG contains IRINOTECAN (IRINOTECAN SUCROSE OCTASULFATE) : 4.3 MG. It is listed in the Health Canada Drug Product Database under DIN 02467135, held by IPSEN BIOPHARMACEUTICALS CANADA INC, supplied as SUSPENSION for INTRAVENOUS administration. Health Canada currently lists it as cancelled post market, status dated 27-Mar-2026. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02467135 |
|---|---|
| Brand name | ONIVYDE |
| Generic / active ingredient | IRINOTECAN (IRINOTECAN SUCROSE OCTASULFATE) : 4.3 MG |
| Manufacturer | IPSEN BIOPHARMACEUTICALS CANADA INC |
| Strength | 4.3 MG |
| Dosage form | SUSPENSION |
| Route of administration | INTRAVENOUS |
| Schedule | Prescription |
| ATC code | L01CE02 IRINOTECAN |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 27-Mar-2026 |
Is IRINOTECAN in shortage in Canada?
A Canadian shortage report is on file for this molecule: Anticipated — reported by PFIZER CANADA ULC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code L01CE02 IRINOTECAN. 8 of 18 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| IRINOTECAN FOR INJECTION | 20 MG | SOLUTION | TEVA CANADA LIMITED | MARKETED | DIN 02312409 |
| IRINOTECAN HYDROCHLORIDE INJECTION | 100 MG / 5 ML | SOLUTION | EUGIA PHARMA INC. | MARKETED | DIN 02528800 |
| IRINOTECAN HYDROCHLORIDE INJECTION | 100 MG / 5 ML | SOLUTION | AURO PHARMA INC | MARKETED | DIN 02501279 |
| IRINOTECAN HYDROCHLORIDE INJECTION | 500 MG / 25 ML | SOLUTION | EUGIA PHARMA INC. | MARKETED | DIN 02528789 |
| IRINOTECAN HYDROCHLORIDE INJECTION | 500 MG / 25 ML | SOLUTION | AURO PHARMA INC | MARKETED | DIN 02501295 |
| IRINOTECAN HYDROCHLORIDE INJECTION USP | 20 MG | SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02258218 |
| IRINOTECAN HYDROCHLORIDE INJECTION USP | 20 MG | SOLUTION | ACCORD HEALTHCARE INC | MARKETED | DIN 02357585 |
| IRINOTECAN HYDROCHLORIDE INJECTION, USP | 20 MG | SOLUTION | GENERIC MEDICAL PARTNERS INC | MARKETED | DIN 02452421 |
| CAMPTOSAR | 20 MG | SOLUTION | PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 02231622 |
| IRINOTECAN | 20 MG | SOLUTION | PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 02410419 |
Who else supplies IRINOTECAN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. IRINOTECAN appears in 137 registered pack listings across 10 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.